Ayuna Kit
Product Images NDC 65862-848

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ayuna (NDC 65862-848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Levo Ethi Fig1)

A horizontal bar chart illustrating the number of women with a blood clot per 10,000 woman years (WY) among four groups: Non-Pregnant Non-COC users (1 to 5 cases), COC users (3 to 9 cases), Pregnant women (5 to 20 cases), and postpartum women within 12 weeks (40 to 65 cases). The chart includes a footnote explaining pregnancy data assumptions regarding duration and rates.*

FDA Label Image

Figure (Levo Ethi Fig2)

A forest plot comparing 'Ever COC use' versus 'Never COC use' and 'Current COC use' versus 'Never use' across multiple studies. The horizontal axis represents effect estimates, with markers and confidence intervals for odds ratios (OR), relative risks (RR), and hazard ratios (HR) from various women's health studies dated 2002 to 2017.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (28 Tablets Pouch))

An illustration depicting a vertical scale of contraceptive effectiveness based on pregnancies per 100 women per year. The scale ranges from 'Fewer Pregnancies' at the top with fewer than 1 pregnancy, to 'More Pregnancies' at the bottom with 85 or more pregnancies. Contraceptive methods are categorized into groups, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patches, vaginal rings with hormones, condoms, diaphragm, abstinence during fertile days, spermicide, withdrawal, and no birth control, arranged by their relative effectiveness.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (168 Tablets Carton))

Packaging label for Ayuna Kit by Aurobindo Pharma Limited showing a 28-day blister pack with tablets arranged by day of the week. The pack includes three rows of orange tablets for weeks 1 to 3 and one row of green tablets for week 4, labeled with days Sunday through Saturday. The label shows the NDC 65862-848-28 and specifies the dosage form as tablets containing levonorgestrel and ethinyl estradiol.*

FDA Label Image

Levo Ethi Fig5

Ayuna kit containing levonorgestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg by Aurobindo Pharma Limited. The label indicates a pouch of 28 tablets with 21 orange active tablets and 7 green inert tablets. The packaging includes product warnings, NDC 65862-848, and distributor information.*

FDA Label Image

Levo Ethi Fig6

Packaging label for Ayuna kit containing levonorgestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg by Aurobindo Pharma Limited. The label indicates 21 orange tablets and 7 green inert tablets per kit, in 6 pouches of 28 tablets each. It mentions dosing, storage instructions, and distribution by Aurobindo Pharma USA, Inc.*

FDA Label Image

Levo Ethi Str1

Chemical structure of Levonorgestrel, showing its molecular formula C21H28O2 and molecular weight 312.4, depicted as a steroid framework with labeled functional groups and bonds.*

FDA Label Image

Levo Ethi Str2

Chemical structure of Ethinyl Estradiol showing its molecular formula (C20H24O2) and molecular weight (296.4). The structure depicts the arrangement of carbon, hydrogen, and oxygen atoms typical of this synthetic estrogen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.